We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

People are also enquiring whether cancer will be a disease of the past like polio or measles after the vaccine is available ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...

But that doesn’t mean an H5N1 avian influenza pandemic isn’t possible ... million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the ...